Amneal Pharmaceuticals, Inc. AMRX Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $197.66M-29.9% | $282.03M+40.1% | $201.25M+181% | $71.54M+20.9% | $59.19M-46.5% | ||
| $4.17M-85.5% | $28.84M-16.9% | $34.73M+260% | $9.64M+46.5% | $6.58M-16.3% | ||
| -$44.01M-526% | $10.34M-86.7% | $77.61M+44.4% | $53.76M+354% | -$21.15M-174% | ||
| $641.62M+5.8% | $606.3M-1.3% | $614.5M+0.9% | $608.97M+1.3% | $601.43M-1.8% | ||
| $103.09M+4.8% | $98.4M-3.1% | $101.51M+19.0% | $85.3M-3.6% | $88.52M+9.7% | ||
| $1.8B-5.9% | $1.91B+4.0% | $1.84B+16.0% | $1.58B+4.9% | $1.51B-4.9% | ||
| $444.61M+0.4% | $442.95M+1.8% | $434.99M-1.2% | $440.33M+3.1% | $427.23M+0.5% | ||
| $593.8M-0.3% | $595.47M-0.1% | $595.95M-0.2% | $597.41M0.0% | $597.5M0.0% | ||
| $534.87M-5.1% | $563.5M-4.2% | $587.94M-9.5% | $649.55M-5.7% | $689.14M-5.9% | ||
| $54.88M-5.1% | $57.81M+46.5% | $39.46M-12.0% | $44.85M-1.3% | $45.42M-24.5% | ||
| $3.54B-3.8% | $3.68B+2.2% | $3.6B+5.2% | $3.42B+1.7% | $3.37B-3.9% | ||
| $6.2M-8.3% | $6.76M-6.1% | $7.2M-76.9% | $31.18M-1.9% | $31.79M-85.8% | ||
| —— | $58.8M— | —— | —— | —— | ||
| $728.05M-17.4% | $881.63M+2.3% | $862.11M-22.1% | $1.11B+2.9% | $1.08B-4.8% | ||
| $2.57B0.0% | $2.57B-0.1% | $2.57B+19.6% | $2.15B-0.4% | $2.15B-0.4% | ||
| —— | $58.37M— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $2.77B-0.7% | $2.79B+0.4% | $2.78B+17.7% | $2.36B+0.6% | $2.35B-2.8% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| —— | —— | —— | —— | —— | ||
| $536.3M-6.2% | $571.79M+1.5% | $563.36M+1.6% | $554.62M+1.6% | $545.81M-2.6% | ||
| -$472.75M+11.6% | -$535.01M+6.2% | -$570.08M+0.4% | -$572.45M+3.8% | -$594.87M+2.0% | ||
| -$112.15M-1.3% | -$110.73M-4.6% | -$105.88M-8.7% | -$97.43M-13.6% | -$85.74M-30.9% | ||
| -$558K-4.3% | -$535K-7.6% | -$497K-19.8% | -$415K-24.6% | -$333K-35.9% | ||
| -$45.41M+35.9% | -$70.79M+35.3% | -$109.46M+2.4% | -$112.12M+14.8% | -$131.67M-20.5% | ||
| $3.54B-3.8% | $3.68B+2.2% | $3.6B+5.2% | $3.42B+1.7% | $3.37B-3.9% | ||
| —— | —— | —— | —— | —— | ||
| $54.88M-5.1% | $57.81M+46.5% | $39.46M-12.0% | $44.85M-1.3% | $45.42M-24.5% | ||
| $534.87M-5.1% | $563.5M-4.2% | $587.94M-9.5% | $649.55M-5.7% | $689.14M-5.9% | ||
| $54.88M-5.1% | $57.81M+46.5% | $39.46M-12.0% | $44.85M-1.3% | $45.42M-24.5% | ||
| $54.88M-5.1% | $57.81M+46.5% | $39.46M-12.0% | $44.85M-1.3% | $45.42M-24.5% | ||
| $70.02M-2.5% | $71.82M-3.6% | $74.48M0.0% | $74.48M+2.1% | $72.98M-14.6% | ||
| $10.55M-75.6% | $43.26M+6.5% | $40.6M-2.2% | $41.52M-4.6% | $43.5M+37.0% | ||
| $2.57B-4.4% | $2.69B+4.5% | $2.57B+18.2% | $2.18B-0.4% | $2.19B-12.3% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $70.02M-2.5% | $71.82M-3.6% | $74.48M0.0% | $74.48M+2.1% | $72.98M-14.6% | ||
| -$558K-4.3% | -$535K-7.6% | -$497K-19.8% | -$415K-24.6% | -$333K-35.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Amneal Pharmaceuticals, Inc.'s total assets?
- Amneal Pharmaceuticals, Inc. (AMRX) holds $3.5B in total assets, up 5.2% year over year.
- How much debt does Amneal Pharmaceuticals, Inc. have?
- Amneal Pharmaceuticals, Inc. carries $2.6B in total debt against -$45.4M of shareholders' equity, a debt-to-equity ratio of 127.90.
- How much cash does Amneal Pharmaceuticals, Inc. have?
- Amneal Pharmaceuticals, Inc. holds $197.7M in cash and equivalents.
- Can Amneal Pharmaceuticals, Inc. cover its short-term obligations?
- Its current ratio is 2.47 — current assets exceed current liabilities.
- Where does Amneal Pharmaceuticals, Inc.'s balance sheet data come from?
- Every line is extracted from Amneal Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
